Trial for MicroPort's Firesorb BVS: FUTURE-III

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.

Also called NCT03660202

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03660202
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03660202. Allocation not applicable; no masking; primary purpose treatment. Start 2019-01 (anticipated); primary completion 2020-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial for MicroPort's Firesorb BVS: FUTURE-III
Acronym
FUTURE-III
Intervention (Device)
Firesorb
Lead sponsor
Shanghai MicroPort Medical (Group) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct03660202
Content hash
20e8b203de059a6269de300c112c1d1454add6f1cd2b468f7a56b24a700269f9